Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Roche Diabetes Care India appoints Gaurav Laroia as General Manager

      Roche Diabetes Care India appoints Gaurav Laroia as General Manager

      Medical Dialogues Bureau3 Jan 2019 9:30 AM IST
      Gaurav Laroia holds a PhD in molecular and cellular biology from New York University School of Medicine, USA and a masters in genetics from the...
      Hetero Labs Limited acquires Tarbis Farma in Spain

      Hetero Labs Limited acquires Tarbis Farma in Spain

      Medical Dialogues Bureau3 Jan 2019 9:15 AM IST
      The acquisition enables Hetero with a strong front-end marketing presence giving Amarox the required commercial infrastructure, product portfolio,...
      SCHOTT KAISHA launches customizable prefillable glass syringes in India

      SCHOTT KAISHA launches customizable prefillable glass syringes in India

      Medical Dialogues Bureau1 Jan 2019 9:30 AM IST
      Rishad Dadachanji, Director, SCHOTT KAISHA shares, "The syriQ BioPure syringes, manufactured in St. Gallen, Switzerland, combine features to ensure...
      Zydus Cadila gets USFDA nod to market acne drug

      Zydus Cadila gets USFDA nod to market acne drug

      Medical Dialogues Bureau31 Dec 2018 1:14 PM IST
      New Delhi: Drug firm Zydus Cadila Saturday said it has received the final nod from the US health regulator to market Clindamycin Phosphate and Benzoyl...
      Healthcare sector may see further consolidation in 2019

      Healthcare sector may see further consolidation in 2019

      Medical Dialogues Bureau31 Dec 2018 1:14 PM IST
      New Delhi: Healthcare sector may see further consolidation in 2019 with tightening of the regulatory environment set to make it difficult for small...
      Cipla recalls 4,800 bottles of anti-HIV tablets from US

      Cipla recalls 4,800 bottles of anti-HIV tablets from US

      Medical Dialogues Bureau31 Dec 2018 9:12 AM IST
      Drug major Cipla is recalling 4,800 bottles of Nevirapine extended-release tablets used for the treatment of human immunodeficiency virus (HIV) from...
      Medtronic Completes Acquisition of Mazor Robotics

      Medtronic Completes Acquisition of Mazor Robotics

      Medical Dialogues Bureau30 Dec 2018 9:35 AM IST
      This acquisition strengthens Medtronic's position as a global innovator in enabling technologies for spine surgery. By combining Medtronic's...
      Novartis signs deal with Gan & Lee as US government seeks to slash insulin cost

      Novartis signs deal with Gan & Lee as US government seeks to slash insulin cost

      Medical Dialogues Bureau30 Dec 2018 9:20 AM IST
      ZURICH: Swiss drugmaker Novartis aims to become a big player in supplying insulin to swelling numbers of diabetics, signing a deal with China's Gan...
      Opiant Pharmaceuticals Licenses Novel CB-1 Receptor Antagonist for Treatment of Acute Cannabinoid Overdose from Sanofi

      Opiant Pharmaceuticals Licenses Novel CB-1 Receptor Antagonist for Treatment of Acute Cannabinoid Overdose from Sanofi

      Medical Dialogues Bureau30 Dec 2018 9:00 AM IST
      New Delhi: Through a press release, Opiant Pharmaceuticals recently announced that it has entered into an exclusive global licensing agreement with...
      Ex-Insys CEO to plead guilty to opioid kickback scheme

      Ex-Insys CEO to plead guilty to opioid kickback scheme

      Medical Dialogues Bureau29 Dec 2018 9:00 AM IST
      BOSTON: The former chief executive of Insys Therapeutics Inc has agreed to plead guilty to participating in a scheme to bribe doctors to prescribe a...
      India eyes Rs 10000 crore FDI in 2 years; PHARMA sectors in focus

      India eyes Rs 10000 crore FDI in 2 years; PHARMA sectors in focus

      Medical Dialogues Bureau28 Dec 2018 10:00 AM IST
      "I have given a target. USD 100 billion of FDI should come from different sectors into India. It will not happen in one year. We have identified...
      Suven Life Sciences gets Product Patents in Brazil and Eurasia

      Suven Life Sciences gets Product Patents in Brazil and Eurasia

      Medical Dialogues Bureau28 Dec 2018 9:30 AM IST
      "We are pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok